Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 marzo 2013

THE NEW ENGLAND JOURNAL OF MEDICINE. Endovascular Treatment for Acute Ischemic Stroke

Alfonso Ciccone, M.D., Luca Valvassori, M.D., Michele Nichelatti, Ph.D., Annalisa Sgoifo, Psy.D., Michela Ponzio, Ph.D., Roberto Sterzi, M.D., and Edoardo Boccardi, M.D. for the SYNTHESIS Expansion Investigators

Intravenous recombinant tissue plasminogen activator (t-PA) is the standard treatment for acute ischemic stroke, but more than half the treated patients do not recover completely or die.1 Alternative treatments, such as endovascular treatment, have been used for many years. As compared with endovascular treatment, intravenous thrombolysis is associated with a lower probability of recanalization2-9 (46% of cases with intravenous t-PA vs. >80% with endovascular treatment10-15). Nevertheless, the two approaches have not been directly compared, recanalization is not invariably associated with a favorable clinical outcome,16 and it is not known whether clinical outcomes are superior with endovascular therapy as compared with intravenous t-PA.

01 diciembre 2014

THE NEW ENGLAND JOURNAL OF MEDICINE. A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke

Olvert A. Berkhemer, M.D., Puck S.S. Fransen, M.D., Debbie Beumer, M.D., Lucie A. van den Berg, M.D., Hester F. Lingsma, Ph.D., Albert J. Yoo, M.D., Wouter J. Schonewille, M.D., Jan Albert Vos, M.D., Ph.D., Paul J. Nederkoorn, M.D., Ph.D., Marieke J.H. Wermer, M.D., Ph.D., Marianne A.A. van Walderveen, M.D., Ph.D., Julie Staals, M.D., Ph.D., Jeannette Hofmeijer, M.D., Ph.D., Jacques A. van Oostayen, M.D., Ph.D., Geert J. Lycklama à Nijeholt, M.D., Ph.D., Jelis Boiten, M.D., Ph.D., Patrick A. Brouwer, M.D., Bart J. Emmer, M.D., Ph.D., Sebastiaan F. de Bruijn, M.D., Ph.D., Lukas C. van Dijk, M.D., L. Jaap Kappelle, M.D., Ph.D., Rob H. Lo, M.D., Ewoud J. van Dijk, M.D., Ph.D., Joost de Vries, M.D., Ph.D., Paul L.M. de Kort, M.D., Ph.D., Willem Jan J. van Rooij, M.D., Ph.D., Jan S.P. van den Berg, M.D., Ph.D., Boudewijn A.A.M. van Hasselt, M.D., Leo A.M. Aerden, M.D., Ph.D., René J. Dallinga, M.D., Marieke C. Visser, M.D., Ph.D., Joseph C.J. Bot, M.D., Ph.D., Patrick C. Vroomen, M.D., Ph.D., Omid Eshghi, M.D., Tobien H.C.M.L. Schreuder, M.D., Roel J.J. Heijboer, M.D., Koos Keizer, M.D., Ph.D., Alexander V. Tielbeek, M.D., Ph.D., Heleen M. den Hertog, M.D., Ph.D., Dick G. Gerrits, M.D., Renske M. van den Berg-Vos, M.D., Ph.D., Giorgos B. Karas, M.D., Ewout W. Steyerberg, M.D., Ph.D., H. Zwenneke Flach, M.D., Henk A. Marquering, Ph.D., Marieke E.S. Sprengers, M.D., Ph.D., Sjoerd F.M. Jenniskens, M.D., Ph.D., Ludo F.M. Beenen, M.D., René van den Berg, M.D., Ph.D., Peter J. Koudstaal, M.D., Ph.D., Wim H. van Zwam, M.D., Ph.D., Yvo B.W.E.M. Roos, M.D., Ph.D., Aad van der Lugt, M.D., Ph.D., Robert J. van Oostenbrugge, M.D., Ph.D., Charles B.L.M. Majoie, M.D., Ph.D., and Diederik W.J. Dippel, M.D., Ph.D. for the MR CLEAN Investigators

Intravenous alteplase administered within 4.5 hours after symptom onset is the only reperfusion therapy with proven efficacy in patients with acute ischemic stroke.1 However, well-recognized limitations of this therapy include the narrow therapeutic time window and contraindications such as recent surgery, coagulation abnormalities, and a history of intracranial hemorrhage.2 Moreover, intravenous alteplase appears to be much less effective at opening proximal occlusions of the major intracranial arteries, which account for more than one third of cases of acute anterior-circulation stroke.3,4 Early recanalization after intravenous alteplase is seen in only about one third of patients with an occlusion of the internal-carotid-artery terminus,5 and the prognosis without revascularization is generally poor for such patients.6 For these reasons, intraarterial treatment is regarded as a potentially important component of the therapeutic armamentarium.

01 diciembre 2013

RADIOLOGY. Cerebral Aneurysms: Accuracy of 320–Detector Row Nonsubtracted and Subtracted Volumetric CT Angiography for Diagnosis

Wenhua Chen, MD, Wei Xing, MD, Ya Peng, MD, Zhongming He, MD, Caoye Wang, MD, Qi Wang, MD

Three-dimensional (3D) rotational digital subtraction angiography (DSA) currently is considered the “gold standard” for the detection of cerebral aneurysms (1,2). However the technique is invasive, time consuming, technically demanding, relatively expensive, and has a 0.12% rate of permanent neurologic complication according to results of a previous prospective, randomized trial (3). Thus, developing an accurate, noninvasive diagnostic imaging modality for aneurysms is an important issue.

01 agosto 2014

CIRCULATION. Evaluation of Interval Times From Onset to Reperfusion in Patients Undergoing Endovascular Therapy in the Interventional Management of Stroke III Trial

Mayank Goyal, MD; Mohammed A. Almekhlafi, MD, MSc; Liqiong Fan, MS; Bijoy K. Menon, MD; Andrew M. Demchuk, MD; Sharon D. Yeatts, PhD; Michael D. Hill, MD, MSc; Thomas Tomsick, MD; Pooja Khatri, MD, MSc; Osama O. Zaidat, MD; Edward C. Jauch, MD; Muneer Eesa, MD; Tudor G. Jovin, MD; Joseph P. Broderick, MD

Background—Meaningful delays occurred in the Interventional Management of Stroke (IMS) III trial. Analysis of the work flow will identify factors contributing to the in-hospital delays.

01 agosto 2014

CIRCULATION. Cerebral and Sinus Vein Thrombosis

Stephan Moll, MD; Beth Waldron, MA

A blood clot in the veins that drain the blood from the brain is called a sinus or cerebral vein thrombosis. It is an uncommon type of clot, affecting about 1500 people in the United States per year.

01 octubre 2013

CIRCULATION. Long-Term Effects of Secondary Prevention on Cognitive Function in Stroke Patients

Abdel Douiri, PhD; Christopher McKevitt, PhD; Eva S. Emmett, MD; Anthony G. Rudd, MD, FRCP; Charles D.A. Wolfe, MD, FFPH

Background—Limited long-term follow-up data exist on the impact of appropriate secondary prevention therapies on cognitive function in patients after first-ever stroke. The aim of this study is to determine the effect of secondary prevention of vascular events on cognitive function after stroke.

30 julio 2013

STROKE. Clinical Sciences. Endovascular Therapy for Asymptomatic Unruptured Intracranial Aneurysms. JR-NET and JR-NET2 Findings

Tomoyoshi Shigematsu, MD; Toshiyuki Fujinaka, MD, PhD; Toshiki Yoshimine, MD, PhD; Hirotoshi Imamura, MD, PhD; Akira Ishii, MD, PhD; Chiaki Sakai, MD, PhD; Nobuyuki Sakai, MD, DMSc for the JR-NET Investigators

Background and Purpose: National registration studies (the Japanese Registry of Neuroendovascular Therapy [JR-NET] and JR-NET2) have determined the current status and outcomes of neuroendovascular therapy (neuro-EVT). We analyzed short-term outcomes of EVT for asymptomatic unruptured intracranial aneurysms (UIAs).

01 agosto 2013

STROKE. Clinical Sciences. Prospective, Multicenter, Single-Arm Study of Mechanical Thrombectomy Using Solitaire Flow Restoration in Acute Ischemic Stroke

Vitor M. Pereira, MD, MSc; Jan Gralla, MD, MSc; Antoni Davalos, MD; Alain Bonafé, MD; Carlos Castaño, MD, PhD; René Chapot, MD; David S. Liebeskind, MD; Raul G. Nogueira, MD; Marcel Arnold, MD; Roman Sztajzel, MD; Thomas Liebig, MD; Mayank Goyal, MD; Michael Besselmann, MD; Antonio Moreno, MD; Gerhard Schroth, MD

Background and Purpose: Mechanical thrombectomy using stent retriever devices have been advocated to increase revascularization in intracranial vessel occlusion. We present the results of a large prospective study on the use of the Solitaire Flow Restoration in patients with acute ischemic stroke.

30 julio 2013

STROKE. Clinical Sciences. Risk of Rupture of Small Anterior Communicating Artery Aneurysms Is Similar to Posterior Circulation Aneurysms

Philippe Bijlenga, MD, PhD; Christian Ebeling, PhD; Max Jaegersberg, MD; Paul Summers, PhD; Alister Rogers, MD; Alan Waterworth, PhD; Jimison Iavindrasana, PhD; Juan Macho, MD; Vitor Mendes Pereira, MD, PhD; Peter Bukovics, PhD; Elio Vivas, MD; Miriam C.J.M. Sturkenboom, PhD; Jessica Wright, BSc, MA; Christoph M. Friedrich, PhD; Alejandro Frangi, PhD; James Byrne, MD; Karl Schaller, MD; Daniel Rufenacht, MD*

Background and Purpose: According to the International Study of Unruptured Intracranial Aneurysms (ISUIA), anterior circulation (AC) aneurysms of <7 mm in diameter have a minimal risk of rupture. It is general experience, however, that anterior communicating artery (AcoA) aneurysms are frequent and mostly rupture at <7 mm. The aim of the study was to assess whether AcoA aneurysms behave differently from other AC aneurysms.

03 septiembre 2013

STROKE. Clinical Sciences. Natural History of Small Unruptured Anterior Circulation Aneurysms A Prospective Cohort Study

Erdem Güresir, MD, PhD; Hartmut Vatter, MD, PhD; Patrick Schuss, MD; Johannes Platz, MD; Jürgen Konczalla, MD; Richard Du Mesnil de Rochement, MD, PhD; Joachim Berkefeld, MD, PhD; Volker Seifert, MD, PhD

Background and Purpose. The natural history of small unruptured intracranial aneurysms of the anterior circulation in the European population is unclear. Therefore, the management of unruptured intracranial aneurysms <7 mm in the anterior circulation is controversial.

01 agosto 2013

STROKE. Clinical Sciences. Migraine and Hemorrhagic Stroke

Simona Sacco, MD; Raffaele Ornello, MD; Patrizia Ripa, MD; Francesca Pistoia, MD, PhD; Antonio Carolei, MD, FAHA

Background and Purpose: Several studies have assessed the possible increased risk of hemorrhagic stroke in migraineurs, drawing differing conclusions. No meta-analysis on the topic has been published to date.

29 agosto 2013

STROKE. Clinical Sciences. Carotid Plaque MRI and Stroke Risk

Ajay Gupta, MD; Hediyeh Baradaran, MD; Andrew D. Schweitzer, MD; Hooman Kamel, MD; Ankur Pandya, PhD; Diana Delgado, MLS; Allison Dunning, MS; Alvin I. Mushlin, MD, ScM; Pina C. Sanelli, MD, MPH

Background and Purpose: MRI characterization of carotid plaque has been studied recently as a potential tool to predict stroke caused by carotid atherosclerosis. We performed a systematic review and meta-analysis to summarize the association of MRI-determined intraplaque hemorrhage, lipid-rich necrotic core, and thinning/rupture of the fibrous cap with subsequent ischemic events.

27 agosto 2013

STROKE. Clinical Sciences. Modelling the Efficiency of Local Versus Central Provision of Intravenous Thrombolysis After Acute Ischemic Stroke

Peter McMeekin, PhD; Jo Gray, MSc; Gary A. Ford, MBBChir; Helen Rodgers, MBChB; Christopher I. Price, MD

Background and Purpose: Prehospital redirection of stroke patients to a regional center is used as a strategy to maximize the provision of intravenous thrombolysis. We developed a model to quantify the benefit of redirection away from local services that were already providing thrombolysis.

03 septiembre 2013

STROKE. Clinical Sciences. Prediction of Poststroke Hemorrhagic Transformation Using Computed Tomography Perfusion

Nawaf Yassi, MBBS, BSc (Med), FRACP; Mark W. Parsons, PhD, FRACP; Søren Christensen, PhD; Gagan Sharma, MCA; Andrew Bivard, PhD; Geoffrey A. Donnan, MD, FRACP; Christopher R. Levi, FRACP; Patricia M. Desmond, MD, FRANZCR; Stephen M. Davis, MD, FRACP; Bruce C.V. Campbell, MBBS, BMedSc, PhD, FRACP

Background and Purpose: Intracerebral hemorrhage is a serious potential complication of stroke thrombolysis. We investigated the optimal computed tomography perfusion (CTP) parameter to predict cerebral parenchymal hematoma (PH) in acute ischemic stroke.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.